The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2913-2916

  Gomes, Larissa G ^a,b   Huang, Ningwu ^a   Agrawal, Vishal ^a   Mendonça, Berenice B ^b   Bachega, Tania A S S ^b   Miller, Walter L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CORTODOXONE; DEOXYCORTICOSTERONE; HYDROXYPROGESTERONE; PROGESTERONE; STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DNA MODIFICATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IN VITRO STUDY; MALE; MICHAELIS CONSTANT; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY; THIN LAYER CHROMATOGRAPHY; WILD TYPE;

EID: 47549119693     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0304     Document Type: Article

References (20)

1. Miller WL, Morel Y 1989 Molecular genetics of 21-hydroxylase deficiency. Ann Rev Genet 23:371-393
2. Speiser PW, White PC 2003 Congenital adrenal hyperplasia. N Engl J Med 349:776-788
3. Jaaskelainen J, Levo A, Voutilainen R, Partanen J 1997 Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 82:3293-3297
4. Bachega TA, Billerbeck AE, Madureira G, Marcondes JA, Longui CA, Leite MV, Arnhold IJ, Mendonça BB 1998 Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 83:4416-4419
5. Krone N, Braun A, Roscher AA, Knorr D, Schwartz HP 2000 Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85:1059-1065
6. Wilson RC, Mercado AB, Cheng KC, New MI 1995 Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80:2322-2329
7. Nimkarn S, Cerame BI, Wei JQ, Dumic M, Zunec R, Brkljacic L, Skrabic V, New MI, Wilson RC 1999 Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab 84:378-381
8. Scott RR, Gomes LG, Huang N, Van Vliet G, Miller WL 2007 Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:2318-2322
9. Miller WL 2005 Regulation of steroidogenesis by electron transfer. Endocrinology 146:2544-2550
10. Flück CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendonca BB, Fujieda K, Miller WL 2004 Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36:228-230
11. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Van Vliet G, Sack J, Flück CE, Miller WL 2005 Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76:729-749
12. Fukami M, Hasegawa T, Horikawa R, Ohashi T, Nishimura G, Homma K, Ogata T 2006 Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res 59:276-280
13. Bachega TA, Brenlha EM, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, Mendonça BB 2002 Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations. J Clin Endocrinol Metab 87:786-790
14. Bachega TA, Billerbeck AE, Madureira G, Arnhold IJ, Medeiros MA, Marcondes JA, Longui CA, Nicolau W, Bloise W, Mendonça BB 1999 Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency. Hum Hered 49:9-14
15. Huang N, Agrawal V, Giacomini KM, Miller WL 2008 Genetics of P450 oxidoreductase. Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci USA 105:1733-1738
16. Pandey AV, Miller WL 2005 Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem 280:13265-13271
17. Agrawal V, Huang N, Miller WL 2008 Pharmacogenetics of P450 oxidoreductase: Effect of sequence variants on activities of CYP1A2 and CYP2C19. Pharmacogenet Genomics 18:569-576
18. Dardis A, Miller WL 2003 Dexamethasone does not exert direct intracellular feedback on steroidogenesis, in human adrenal NCI-H295 A cells. J Endocrinol 179:131-142
19. Dhir V, Ivison HE, Krone N, Shackleton CHL, Doherty AJ, Stewart PM, Arlt W 2007 Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P. Mol Endocrinol 21:1958-1968
20. Pandey AV, Kempna P, Hofer G, Mullis PE, Flück CE 2007 Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. Mol Endocrinol 21:2579-2595